Medigene AG sell fenjal
Start price
20.11.16
/
50%
€9.67
Target price
02.01.17
€6.00
Performance (%)
30.37%
End price
02.01.17
€12.60
Summary
This prediction ended on 02.01.17 with a price of €12.60. The SELL prediction by fenjal for Medigene AG was trending in the completely wrong direction and closed with a performance of 30.37%. fenjal has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Medigene AG | -0.855% | -0.855% | -38.462% | -70.483% |
iShares Core DAX® | -0.543% | 1.491% | 13.638% | 16.760% |
iShares Nasdaq 100 | -2.696% | -1.235% | 31.879% | 45.155% |
iShares Nikkei 225® | -2.863% | 2.491% | 12.078% | 7.840% |
iShares S&P 500 | -1.105% | 0.013% | 26.888% | 43.056% |
Comments by fenjal for this prediction
In the thread Medigene AG diskutieren
fenjal stimmt der fundamentalen Bewertung mit dem Ergebnis 'überbewertet' zu
fenjal stimmt am 20.11.2016 der fundamentalen Bewertung mit dem Ergebnis überbewertet zu.
(Vom Mitglied beendet)